Therapeutic Drug Monitoring Market to Grow at a CAGR of 9.4% by 2026

1
(No Transcript)
2
Therapeutic Drug Monitoring Market
MARKET OPPORTUNITY OVER NEXT 4 YEARS
by product
KEY MARKET PLAYERS
CAGR of
2022 2026

• Abbott (US)
• Thermo Fisher Scientific (US)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Siemens Healthineers AG (Germany)
• Danaher Corporation (US)
• Bio-Rad Laboratories (US)

CAGR

• Consumables
• Equipment-Immunoassay Analyzers
• Chromatography MS Detectors
• Clinical Chemistry Analyzers

• BY REGION
• North America
• Europe
• Asia Pacific
• Rest of the World

By class

• Antiepileptic Drugs
• Antibiotic Drugs
• Immunosuppressant Drugs
• Antiarrhythmic Drugs
• Bronchodilator Drugs
• Psychoactive Drugs

3
According to the new market research report
"Therapeutic Drug Monitoring Market by Product
(Consumables, Equipment-Immunoassay Analyzers,
Chromatography MS Detectors, Clinical Chemistry
Analyzers), Technology, Class of drugs, End user
and Region - Global Forecast to 2026", published
by MarketsandMarkets, the global market is
projected to reach USD 2.7 billion by 2026 from
USD 1.6 billion in 2020, at a CAGR of 9.4
during the forecast period. Browse in-depth TOC
on "Therapeutic Drug Monitoring Market" 318
Tables 42 Figures 298 Pages Download PDF
Brochure https//www.marketsandmarkets.com/pdfdo
wnloadNew.asp?id155350443
4
The growth of this market is majorly driven by
the rising number of organ transplant procedures,
the use of TDM across various therapeutic fields,
the increasing preference for precision medicine,
a growing focus on RD related to TDM, and
technological advancements in immunoassay
instruments. However, the need for high capital
investments and the reluctance of small hospitals
to offer TDM services may restrain the growth of
this market. Consumables in the product segment
to witness the highest growth during the forecast
period. Based on the product, the Therapeutic
Drug Monitoring market is segmented into
Consumables, Equipment-Immunoassay Analyzers,
Chromatography MS Detectors, Clinical Chemistry
Analyzers. The Consumables segment is projected
to grow at the highest CAGR during the forecast
period. The major factors contributing to the
growth of this market are the requirement of
repeat purchase of kits and reagents, coupled
with the increasing number of immunoassay tests
being performed across the globe. Request Sample
Pages https//www.marketsandmarkets.com/requests
ampleNew.asp?id155350443
5
North America dominates the global Therapeutic
Drug Monitoring industry The TDM Market is
segmented into four major regional segments,
namely, North America, Europe, Asia Pacific, and
the Rest of the World. In 2021, North America
accounted for the largest share of the market.
The large share of North America can be
attributed to increasing per capita healthcare
expenditure and the presence of technologically
advanced healthcare infrastructure. The major
players in the Therapeutic Drug Monitoring market
are Abbott (US), Thermo Fisher Scientific (US),
F. Hoffmann-La Roche Ltd. (Switzerland), Siemens
Healthineers AG (Germany), Danaher Corporation
(US), Bio-Rad Laboratories (US), bioMérieux SA
(France), Theradiag SA (France), Grifols S.A.
(Spain), Exagen Inc. (US), R-Biopharm AG
(Germany), ApDia Group (Belgium), UTAK (US),
Randox Laboratories Ltd. (Ireland), ARK
Diagnostics, Inc. (US). Speak to
Analyst https//www.marketsandmarkets.com/speakto
analystNew.asp?id155350443
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies'
revenues. Currently servicing 7500 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions. Our 850 fulltime analyst and
SMEs at MarketsandMarkets are tracking global
high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve. MarketsandMarkets's flagship
competitive intelligence and market research
platform, "Knowledge Store" connects over 200,000
markets and entire value chains for deeper
understanding of the unmet insights along with
market sizing and forecasts of niche markets.
7
Contact Mr. Aashish Mehra MarketsandMarkets
INC. 630 Dundee Road Suite 430 Northbrook, IL
60062 USA 1-888-600-6441 Email
sales_at_marketsandmarkets.com View Full Report -
https//www.marketsandmarkets.com/Market-Reports/t
herapeutic-drug-monitoring-market-155350443.html